Lifeward Ltd. Files 8-K

Ticker: LFWD · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1607962

Sentiment: neutral

Topics: 8-K, corporate-filing, financials

TL;DR

Lifeward Ltd. (formerly ReWalk Robotics) filed a standard 8-K on Jan 13, 2025.

AI Summary

Lifeward Ltd. filed an 8-K on January 13, 2025, to report other events and financial statements. The company, formerly known as ReWalk Robotics Ltd., is based in Marlborough, MA, and operates in the orthopedic, prosthetic, and surgical appliances sector.

Why It Matters

This filing indicates routine corporate activity and the submission of financial information, which is standard for publicly traded companies.

Risk Assessment

Risk Level: low — This is a routine 8-K filing for corporate events and financial statements, not indicating any specific new risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of January 13, 2025.

What was Lifeward Ltd. previously known as?

Lifeward Ltd. was formerly known as ReWalk Robotics Ltd. and prior to that, Argo Medical Technologies Ltd.

Where are Lifeward Ltd.'s principal executive offices located?

Lifeward Ltd.'s principal executive offices are located at 200 Donald Lynch Blvd., Marlborough, MA 01752.

What is the SIC code for Lifeward Ltd.?

The Standard Industrial Classification (SIC) code for Lifeward Ltd. is 3842, which pertains to Orthopedic, Prosthetic & Surgical Appliances & Supplies.

When is the reported fiscal year end for Lifeward Ltd.?

The fiscal year end for Lifeward Ltd. is December 31 (1231).

Filing Stats: 467 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-01-13 08:00:45

Filing Documents

01 Other Events

Item 8.01 Other Events. On January 13, 2025, Lifeward Ltd. (the "Company") issued a press release announcing its decision to cancel its Extraordinary General Meeting of Shareholders that was scheduled for January 13, 2025 and to withdraw from consideration by the shareholders of the Company the proposals set forth in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on November 25, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Press release dated January 13, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Lifeward Ltd. Date: January 13, 2025 By: /s/ Mike Lawless Name: Mike Lawless Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing